Style | Citing Format |
---|---|
MLA | Tondro F, et al.. "Inhibition by Hypericin of Tongue Squamous Carcinoma Cell Proliferation and Treatment of Resistance in Dental Pulp Stem Cells." Revista Brasileira de Farmacognosia, vol. , no. , 2024, pp. -. |
APA | Tondro F, Shahbazi S, Shahriari F, Ansari AM, Forouzesh F, Ghadirian R, Shayeghan M, Salaritabar A, Javidi MA (2024). Inhibition by Hypericin of Tongue Squamous Carcinoma Cell Proliferation and Treatment of Resistance in Dental Pulp Stem Cells. Revista Brasileira de Farmacognosia, (), -. |
Chicago | Tondro F, Shahbazi S, Shahriari F, Ansari AM, Forouzesh F, Ghadirian R, Shayeghan M, Salaritabar A, Javidi MA. "Inhibition by Hypericin of Tongue Squamous Carcinoma Cell Proliferation and Treatment of Resistance in Dental Pulp Stem Cells." Revista Brasileira de Farmacognosia , no. (2024): -. |
Harvard | Tondro F et al. (2024) 'Inhibition by Hypericin of Tongue Squamous Carcinoma Cell Proliferation and Treatment of Resistance in Dental Pulp Stem Cells', Revista Brasileira de Farmacognosia, (), pp. -. |
Vancouver | Tondro F, Shahbazi S, Shahriari F, Ansari AM, Forouzesh F, Ghadirian R, et al.. Inhibition by Hypericin of Tongue Squamous Carcinoma Cell Proliferation and Treatment of Resistance in Dental Pulp Stem Cells. Revista Brasileira de Farmacognosia. 2024;():-. |
BibTex | @article{ author = {Tondro F and Shahbazi S and Shahriari F and Ansari AM and Forouzesh F and Ghadirian R and Shayeghan M and Salaritabar A and Javidi MA}, title = {Inhibition by Hypericin of Tongue Squamous Carcinoma Cell Proliferation and Treatment of Resistance in Dental Pulp Stem Cells}, journal = {Revista Brasileira de Farmacognosia}, volume = {}, number = {}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Tondro F AU - Shahbazi S AU - Shahriari F AU - Ansari AM AU - Forouzesh F AU - Ghadirian R AU - Shayeghan M AU - Salaritabar A AU - Javidi MA TI - Inhibition by Hypericin of Tongue Squamous Carcinoma Cell Proliferation and Treatment of Resistance in Dental Pulp Stem Cells JO - Revista Brasileira de Farmacognosia VL - IS - SP - EP - PY - 2024 ER - |